Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Glucurolactone |
Is a |
False |
Heparinoid (substance) |
Inferred relationship |
Some |
|
Danaparoid (substance) |
Is a |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
|
Heparinoid adverse reaction (disorder) |
Causative agent (attribute) |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Allergy to heparinoid (finding) |
Causative agent (attribute) |
False |
Heparinoid (substance) |
Inferred relationship |
Some |
|
Product containing precisely heparinoid 3 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparinoid (substance) |
Inferred relationship |
Some |
|
Heparinoid 3 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparinoid (substance) |
Inferred relationship |
Some |
|
Product containing heparinoid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid+hyaluronidase 50/150units/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparinoid (substance) |
Inferred relationship |
Some |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparinoid (substance) |
Inferred relationship |
Some |
|
Product containing precisely heparinoid 8 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparinoid (substance) |
Inferred relationship |
Some |
|
Heparinoid 2 mg/g and lauromacrogol 400 50 mg/g rectal ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparinoid (substance) |
Inferred relationship |
Some |
|
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparinoid (substance) |
Inferred relationship |
Some |
|
Allergy to heparinoid (finding) |
Causative agent (attribute) |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Danaparoid sodium (substance) |
Is a |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
|
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Heparinoid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Heparinoid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely heparinoid 8 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely heparinoid 8 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid 3 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid 3 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely heparinoid 3 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely heparinoid 3 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid 2 mg/g and lauromacrogol 400 50 mg/g rectal ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Heparinoid (substance) |
Inferred relationship |
Some |
2 |
Heparinoid 2 mg/g and lauromacrogol 400 50 mg/g rectal ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Heparinoid (substance) |
Inferred relationship |
Some |
2 |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid- and salicylic acid-containing product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid- and lauromacrogol 400-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid- and lauromacrogol 400-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Product containing heparinoid and salicylic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Product containing heparinoid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid- and salicylic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Product containing only heparinoid and lauromacrogol 400 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid and salicylic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid and lauromacrogol 400 only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid and salicylic acid only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid and salicylic acid only product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid 2 mg/g and lauromacrogol 400 50 mg/g rectal ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |
Heparinoid 2 mg/g and lauromacrogol 400 50 mg/g rectal ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Heparinoid (substance) |
Inferred relationship |
Some |
1 |